Back to Trades
Sell4
QUEST DIAGNOSTICS INC
DGX
Total Value
$3.5M
Net $1.8M sold
Sales
$1.8M
3 transactions
Company Information
- Company Name
- QUEST DIAGNOSTICS INC
- Ticker Symbol
- DGX
- CIK
- 0001022079
Insider Information
- Role
- SVP, Clinical Solutions
- Location
- SECAUCUS, NJ
Officer
Filing Details
- Filing Date
- Aug 1, 2025
- Transaction Date
- Jul 30, 2025
- Accession Number
- 0001022079-25-000195
- Form Type
- 4
- Net Trading Amount
- -$1.8M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 30, 2025 | Common Stock | 3,045 | $86.63 | Exercise | $263.8K |
| Jul 30, 2025 | Common Stock | 3,045 | $167.40 | Sale | $509.7K |
| Jul 30, 2025 | Common Stock | 5,224 | $112.17 | Exercise | $586.0K |
| Jul 30, 2025 | Common Stock | 5,224 | $167.40 | Sale | $874.5K |
| Jul 31, 2025 | Common Stock | 2,210 | $170.00 | Sale | $375.7K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 30, 2025 | Derivative | 3,045 | $86.63 | Exercise | $263.8K |
| Jul 30, 2025 | Derivative | 5,224 | $112.17 | Exercise | $586.0K |
Footnotes
- (F1)This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- (F2)These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- (F3)The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022.
- (F4)The options vested in three annual installments beginning with the first on February 18, 2021, the second on February 18, 2022 and the final on February 18, 2023.